Pricing
Login
Home
Charts
Search
Watchlist
Products

Accretion Pharmaceuticals Ltd

ACCPL
₹207.00+1.47%20 Nov 2026
Reports
Pharma CRAMS

Accretion Pharmaceuticals Ltd

ACCPL
₹207.00
+1.47%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹230Cr
Close
Close Price
₹207.00
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
17.54
PS
Price To Sales
2.28
Revenue
Revenue
₹101Cr
Rev Gr TTM
Revenue Growth TTM
22.27%
PAT Gr TTM
PAT Growth TTM
44.49%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
0131939444655
Growth YoY
Revenue Growth YoY%
190.7135.718.225.8
Expenses
ExpensesCr
0111431373843
Operating Profit
Operating ProfitCr
03487812
OPM
OPM%
19.223.419.416.217.222.2
Other Income
Other IncomeCr
0000000
Interest Expense
Interest ExpenseCr
0011001
Depreciation
DepreciationCr
0000011
PBT
PBTCr
02477712
Tax
TaxCr
0112223
PAT
PATCr
0124558
Growth YoY
PAT Growth YoY%
190.693.113.672.6
NPM
NPM%
11.213.311.210.910.714.9
EPS
EPS₹
0.02.03.15.34.64.47.4
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
0131939444655
Growth YoY
Revenue Growth YoY%
190.7135.718.225.8
Expenses
ExpensesCr
0111431373843
Operating Profit
Operating ProfitCr
03487812
OPM
OPM%
19.223.419.416.217.222.2
Other Income
Other IncomeCr
0000000
Interest Expense
Interest ExpenseCr
0011001
Depreciation
DepreciationCr
0000011
PBT
PBTCr
02477712
Tax
TaxCr
0112223
PAT
PATCr
0124558
Growth YoY
PAT Growth YoY%
190.693.113.672.6
NPM
NPM%
11.213.311.210.910.714.9
EPS
EPS₹
0.02.03.15.34.64.47.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2229135790101
Growth
Revenue Growth%
31.8-54.5329.756.222.3
Expenses
ExpensesCr
212711467581
Operating Profit
Operating ProfitCr
223121520
OPM
OPM%
7.46.719.220.716.719.9
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
110111
Depreciation
DepreciationCr
110112
PBT
PBTCr
002101319
Tax
TaxCr
001334
PAT
PATCr
00171013
Growth
PAT Growth%
25.01,392.8355.142.344.5
NPM
NPM%
0.40.311.211.810.813.0
EPS
EPS₹
2.08.59.011.8
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
2229135790101
Growth
Revenue Growth%
31.8-54.5329.756.222.3
Expenses
ExpensesCr
212711467581
Operating Profit
Operating ProfitCr
223121520
OPM
OPM%
7.46.719.220.716.719.9
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
110111
Depreciation
DepreciationCr
110112
PBT
PBTCr
002101319
Tax
TaxCr
001334
PAT
PATCr
00171013
Growth
PAT Growth%
25.01,392.8355.142.344.5
NPM
NPM%
0.40.311.211.810.813.0
EPS
EPS₹
2.08.59.011.8
Sales CAGR
1 Year56%
3 Years45%
5 Years-
TTM-
EBITDA CAGR
1 Year26%
3 Years96%
5 Years-
TTM-
PAT CAGR
1 Year42%
3 Years359%
5 Years-
TTM-
Avg. ROCE
1 Year21%
3 Years24%
5 Years-
TTM26%
CFO / EBITDA
1 Year-97%
3 Years-91%
5 Years-
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
481111
Reserves
ReservesCr
174452
Current Liabilities
Current LiabilitiesCr
152321
Non Current Liabilities
Non Current LiabilitiesCr
711
Total Liabilities
Total LiabilitiesCr
27407787
Current Assets
Current AssetsCr
223360
Non Current Assets
Non Current AssetsCr
5616
Total Assets
Total AssetsCr
27407787
Financial YearMar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
481111
Reserves
ReservesCr
174452
Current Liabilities
Current LiabilitiesCr
152321
Non Current Liabilities
Non Current LiabilitiesCr
711
Total Liabilities
Total LiabilitiesCr
27407787
Current Assets
Current AssetsCr
223360
Non Current Assets
Non Current AssetsCr
5616
Total Assets
Total AssetsCr
27407787

Cash Flow

Standalone
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-12-1-15
Investing Cash Flow
Investing Cash FlowCr
-5-2-9
Financing Cash Flow
Financing Cash FlowCr
17227
Net Cash Flow
Net Cash FlowCr
004
Free Cash Flow
Free Cash FlowCr
-17-2-23
CFO To PAT
CFO To PAT%
-771.0-9.1-150.3
CFO To EBITDA
CFO To EBITDA%
-449.0-5.2-97.1
Financial YearMar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-12-1-15
Investing Cash Flow
Investing Cash FlowCr
-5-2-9
Financing Cash Flow
Financing Cash FlowCr
17227
Net Cash Flow
Net Cash FlowCr
004
Free Cash Flow
Free Cash FlowCr
-17-2-23
CFO To PAT
CFO To PAT%
-771.0-9.1-150.3
CFO To EBITDA
CFO To EBITDA%
-449.0-5.2-97.1

Ratios

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
71230
Price To Earnings
Price To Earnings
7.317.5
Price To Sales
Price To Sales
0.82.3
Price To Book
Price To Book
1.34.2
EV To EBITDA
EV To EBITDA
5.311.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.329.525.525.5
OPM
OPM%
7.46.719.220.716.719.9
NPM
NPM%
0.40.311.211.810.813.0
ROCE
ROCE%
12.638.120.825.5
ROE
ROE%
27.244.417.720.9
ROA
ROA%
5.417.012.615.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
71230
Price To Earnings
Price To Earnings
7.317.5
Price To Sales
Price To Sales
0.82.3
Price To Book
Price To Book
1.34.2
EV To EBITDA
EV To EBITDA
5.311.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.329.525.525.5
OPM
OPM%
7.46.719.220.716.719.9
NPM
NPM%
0.40.311.211.810.813.0
ROCE
ROCE%
12.638.120.825.5
ROE
ROE%
27.244.417.720.9
ROA
ROA%
5.417.012.615.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr2,7221,9841,812230149128123
Close PriceClose₹220.76961.25115.57207.00135.00158.0057.08
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE30.4117.5417.2617.34
Price To SalesPS1.472.190.662.281.091.834.58
RevenueRevenueCr1,8519042,7561011377027
Revenue Growth TTMRev Gr TTM%8.9%19.0%-0.1%22.3%54.7%-1.4%
PAT Growth TTMPAT Gr TTM%-149.5%8.9%-184.9%44.5%-3.4%51.4%
Market CapitalizationMkt CapCr2,7221,9841,812230149128123
Close PriceClose₹220.76961.25115.57207.00135.00158.0057.08
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE30.4117.5417.2617.34
Price To SalesPS1.472.190.662.281.091.834.58
RevenueRevenueCr1,8519042,7561011377027
Revenue Growth TTMRev Gr TTM%8.9%19.0%-0.1%22.3%54.7%-1.4%
PAT Growth TTMPAT Gr TTM%-149.5%8.9%-184.9%44.5%-3.4%51.4%
Annual Reports
FY2025
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Load More
Interviews